Physician profile
Cara Ryan Downey
NPI 1013142165
$9,487.26
in general payments reported to CMS, 2019-2025
24 companies · $1,031 in 2025
The $1,031 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,643 · 2020: $913 · 2021: $1,672 · 2022: $2,242 · 2023: $1,116 · 2024: $870 · 2025: $1,031.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,480 · Long Term Medical Supply Or Device Loan: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,480.46 |
| Long Term Medical Supply Or Device Loan | $537.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,932.21 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Galderma Laboratories, L.P. | $1,239.86 | 2020-2025 | Dysport |
| Davol INC. | $1,156.42 | 2019-2024 | Phasix Mesh |
| Sientra, INC. | $932.17 | 2020-2021 | |
| Integra Lifesciences Corporation | $721.42 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Allergan, INC. | $712.52 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $638.56 | 2019-2021 | |
| Medtronic, INC. | $383.63 | 2022-2024 | Intellis Adaptivestim, V-Loc 180, Venaseal |
| Abbvie INC. | $285.52 | 2023-2025 | Alloderm |
| Revance Therapeutics, INC. | $255.22 | 2024-2025 | Daxxify |
| Mml US, INC. | $186.92 | 2022 | |
| Stryker Corporation | $176.97 | 2020-2025 | Optablate, Omnicurve |
| Abbott Laboratories | $160.25 | 2022 | |
| Tepha INC | $159.59 | 2019 | |
| Zimmer Biomet Holdings, INC. | $148.62 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $123.60 | 2019-2022 | |
| Merz North America, INC. | $115.46 | 2019 | |
| Apyx Medical Corporation | $46.05 | 2020 | |
| Seqirus USA INC | $27.54 | 2025 | Flucelvax |
| Vertex Pharmaceuticals Incorporated | $24.77 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $20.83 | 2023 | Seglentis |
| Tela Bio, INC. | $13.50 | 2024 | Ovitex 2s |
| Pacira Pharmaceuticals Incorporated | $13.35 | 2021 | |
| Innovation Technologies INC | $12.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Downey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.